The results proved that MYB expression showed significant difference among several immune subtypes and molecular subtypes in most cancers, which could demonstrate that MYB is a valuable pan-cancer diagnostic biomarker and involved in the tumor immune environment regulation. The gene discussed is MYB; the disease is neoplasm.